Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients.
Transpl Infect Dis
; 23(1): e13449, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-32810315
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
/
Hepatitis C, Chronic
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Transpl Infect Dis
Journal subject:
TRANSPLANTE
Year:
2021
Type:
Article
Affiliation country:
United States